FDA Approves Digital Therapeutic for the Treatment of Postpartum Depression
MamaLift Plus is a prescription?only digital therapeutic intervention for the treatment of mild to moderate postpartum depression using several different neurobehavioral interventions.
Sedating Antihistamines and Sleep: Safe for Breastfeeding Women and Their Babies?
Sleep disruption and insomnia are commonplace among postpartum women, and they often ask what medications are compatible with breastfeeding. What about sedating antihistamines?
Using AI and Natural Language Processing To Identify Postpartum Women with PTSD Related to Childbirth
Establishing noninvasive and low-cost data collection based on childbirth narratives for the identification of women with CB-PTSD could serve as an important first step to complement more extensive methods.
In Women with Bipolar Disorder, Loss of Sleep Related to Childbirth Increases Risk for Postpartum Psychosis
Loss of at least one night’s sleep at the time of labor and delivery is a potent risk factor for postpartum psychosis in women with bipolar disorder.
Do SSRI Antidepressants Lower Risk of Preeclampsia? Maybe, But It’s Complicated
There is evidence that depression itself can increase risk for preeclampsia. In women with more severe depression, treatment with an SSRI antidepressant may decrease risk.
Resource: Check Out the Provider Directory from Postpartum Support International
We at the Center for Women's Mental Health rely so much upon Postpartum Support International. The organization helps women with perinatal mood and anxiety disorders to find specialized treatment all over the world. The PSI Provider Directory focuses specifically on connecting Perinatal Mental Health Professionals with those that are seeking [...]
Weekly Roundup for April 5, 2024: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Maternal Depression Negatively Affects Fetal Growth During Critical Stage of Development
In this prospective cohort study, the researchers observed an association between maternal depressive symptoms during pregnancy with slower rates of fetal growth.